Dados B3 › PDTC3 × TOTS3
PDTC3 × TOTS3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | PDTC3 | TOTS3 | year |
|---|---|---|---|
| ROE | 0.0%! | 18.2% | 2025 |
| ROIC | 6.7%! | 17.8% | 2025 |
| ROA | 1.0%! | 10.2% | 2025 |
| Gross margin | 35.8%! | 70.3% | 2025 |
| EBIT margin | 7.9%! | 19.5% | 2025 |
| Net margin | 2.4%! | 16.0% | 2025 |
| Net debt/EBITDA | 4.61x! | 0.03x | 2025 |
| Current ratio | 2.96x! | 1.96x | 2025 |
| Revenue growth (1y) | -2.3%! | 17.4% | 2025 |
| Revenue growth (5y CAGR) | -72.0%! | 17.3% | 2025 |
| Piotroski F-Score | 8/9! | 7/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | PDTC3 | TOTS3 | year |
|---|---|---|---|
| P/E | 19.62x | 25.47x | 2022 × 2025 |
| P/B | 1.41x | 4.45x | 2022 × 2025 |
| EV/EBITDA | 6.20x | 15.55x | 2022 × 2025 |
| FCF yield | — | 4.2% | 2022 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:20 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:20 UTC. If this does not match /saude, you are reading a cached copy.